Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026)
Phibro Animal Health (PAHC) posted quarterly Total Current Liabilities of $281.9 million for Q1 2026, up 5.77% year-over-year from $266.5 million in Q1 2025, and little changed quarter-over-quarter from $282.4 million in Q4 2025.
Phibro Animal Health (PAHC) Total Current Liabilities (2013 - 2026) Analysis & Trends
Phibro Animal Health's Total Current Liabilities history runs 14 years deep, the most recent figure standing at $281.9 million for Q1 2026.
- In Q1 2026, Total Current Liabilities rose 5.77% year-over-year to $281.9 million; the TTM figure through Mar 2026 stood at $281.9 million (up 5.77% YoY), while the FY2025 annual figure was $293.5 million, up 43.76% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $281.9 million, roughly flat from $282.4 million in the prior quarter.
- The five-year high for Total Current Liabilities was $293.5 million in Q2 2025, with the low at $165.3 million in Q1 2023.
- The 5-year median for Total Current Liabilities is $189.1 million (2024), against an average of $212.8 million.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities dropped 11.65% in 2023, then jumped 52.71% in 2025.
- Phibro Animal Health's Total Current Liabilities stood at $167.6 million in 2022, then advanced by 12.03% to $187.7 million in 2023, then grew by 24.24% to $233.2 million in 2024, then increased by 21.06% to $282.4 million in 2025, then decreased by 0.18% to $281.9 million in 2026.
- Business Quant data shows PAHC's Total Current Liabilities at $281.9 million in Q1 2026, $282.4 million in Q4 2025, and $270.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 1.79 Bn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 281.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 281.87 Mn |
| Dec 31, 2025 | 282.37 Mn |
| Sep 30, 2025 | 270.14 Mn |
| Jun 30, 2025 | 293.47 Mn |
| Mar 31, 2025 | 266.48 Mn |
| Dec 31, 2024 | 233.25 Mn |
| Sep 30, 2024 | 176.89 Mn |
| Jun 30, 2024 | 204.15 Mn |
| Mar 31, 2024 | 189.07 Mn |
| Dec 31, 2023 | 187.74 Mn |
| Sep 30, 2023 | 172.36 Mn |
| Jun 30, 2023 | 176.00 Mn |
| Mar 31, 2023 | 165.31 Mn |
| Dec 31, 2022 | 167.57 Mn |
| Sep 30, 2022 | 172.50 Mn |
| Jun 30, 2022 | 190.83 Mn |
| Mar 31, 2022 | 187.10 Mn |
| Dec 31, 2021 | 166.63 Mn |
| Sep 30, 2021 | 152.59 Mn |
| Jun 30, 2021 | 164.12 Mn |